GPER1 and inflammatory skin disease: Together, our results identify GPER1 as a negative regulator of keratinocyte hyperproliferation and skin inflammation, suggesting that modulation of this pathway may represent a therapeutic strategy for hyperproliferative inflammatory skin diseases such as psoriasis.